The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

The SetPoint System is an implanted device that stimulates the vagus nerve once a day. It was tested through a clinical trial at Northwell Health.

The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.

A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...

SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve.

The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...

Setpoint, which is based in Austin and New York, launched a $31 million Series B round led by Andreessen Horowitz, a storied Silicon Valley investor that has backed giants such as Airbnb, Slack ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid arthritis.The device is an implantable, integrated neurostimulator about the ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...